{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T12:19:14Z","timestamp":1772367554195,"version":"3.50.1"},"reference-count":21,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1016\/j.dld.2012.12.017","type":"journal-article","created":{"date-parts":[[2013,2,18]],"date-time":"2013-02-18T11:50:33Z","timestamp":1361188233000},"page":"612-615","source":"Crossref","is-referenced-by-count":13,"title":["Macrophage stimulating protein variation enhances the risk of sporadic extrahepatic cholangiocarcinoma"],"prefix":"10.1016","volume":"45","author":[{"given":"Marcin","family":"Krawczyk","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aksana","family":"H\u00f6blinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florentina","family":"Mihalache","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"Gr\u00fcnhage","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica","family":"Acalovschi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"Lammert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent","family":"Zimmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.dld.2012.12.017_bib0005","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1002\/hep.22310","article-title":"Cholangiocarcinoma: advances in pathogenesis, diagnosis, and treatment","volume":"48","author":"Blechacz","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2012.12.017_bib0010","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/nrgastro.2011.20","article-title":"Cholangiocarcinoma \u2013 controversies and challenges","volume":"8","author":"Patel","year":"2011","journal-title":"Nature Reviews Gastroenterology & Hepatology"},{"key":"10.1016\/j.dld.2012.12.017_bib0015","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/MOG.0b013e3283444862","article-title":"Genetics in liver disease: new concepts","volume":"27","author":"Zimmer","year":"2011","journal-title":"Current Opinions in Gastroenterology"},{"key":"10.1016\/j.dld.2012.12.017_bib0020","unstructured":"Chaiteerakij R, Yang JD, Harmsen WS, et al. Risk factors for intrahepatic cholangiocarcinoma: Association between metformin use and reduced cancer risk. Hepatology, in press."},{"key":"10.1016\/j.dld.2012.12.017_bib0025","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/hep.24351","article-title":"Risk factors for cholangiocarcinoma","volume":"54","author":"Tyson","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2012.12.017_bib0030","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1365-2036.2010.04534.x","article-title":"Heterozygosity for the alpha1-antitrypsin Z allele may confer genetic risk of cholangiocarcinoma","volume":"33","author":"Mihalache","year":"2011","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1016\/j.dld.2012.12.017_bib0035","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1159\/000324688","article-title":"Genetic factors in the pathogenesis of cholangiocarcinoma","volume":"29","author":"Wadsworth","year":"2011","journal-title":"Digestive Diseases"},{"key":"10.1016\/j.dld.2012.12.017_bib0040","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1002\/hep.24570","article-title":"Cancer surveillance in patients with primary sclerosing cholangitis","volume":"54","author":"Razumilava","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2012.12.017_bib0045","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/ng.728","article-title":"Genome-wide association analysis in primary sclerosing cholangitis identifies two non-HLA susceptibility loci","volume":"43","author":"Melum","year":"2011","journal-title":"Nature Genetics"},{"key":"10.1016\/j.dld.2012.12.017_bib0050","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/mi.2007.15","article-title":"Gene-centric association mapping of chromosome 3p implicates MST1 in IBD pathogenesis","volume":"1","author":"Goyette","year":"2008","journal-title":"Mucosal Immunology"},{"key":"10.1016\/j.dld.2012.12.017_bib0055","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/S0002-9440(10)63887-4","article-title":"Gene expression patterns in renal cell carcinoma assessed by complementary DNA microarray","volume":"162","author":"Higgins","year":"2003","journal-title":"American Journal of Pathology"},{"key":"10.1016\/j.dld.2012.12.017_bib0060","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/35090585","article-title":"Delineation of prognostic biomarkers in prostate cancer","volume":"412","author":"Dhanasekaran","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.dld.2012.12.017_bib0065","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1111\/j.1478-3231.2005.01106.x","article-title":"p53 Mutations in human cholangiocarcinoma: a review","volume":"25","author":"Khan","year":"2005","journal-title":"Liver International"},{"key":"10.1016\/j.dld.2012.12.017_bib0070","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/sj.onc.1209061","article-title":"Repression of the MSP\/MST-1 gene contributes to the antiapoptotic gain of function of mutant p53","volume":"25","author":"Zalcenstein","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.dld.2012.12.017_bib0075","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1136\/gutjnl-2011-301748","article-title":"Guidelines for the diagnosis and treatment of cholangiocarcinoma: an update","volume":"61","author":"Khan","year":"2012","journal-title":"Gut"},{"key":"10.1016\/j.dld.2012.12.017_bib0080","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jhep.2009.04.009","article-title":"EASL Clinical Practice Guidelines: management of cholestatic liver diseases","volume":"51","author":"Beuers","year":"2009","journal-title":"Journal of Hepatology"},{"key":"10.1016\/j.dld.2012.12.017_bib0085","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1469-1809.2009.00552.x","article-title":"Attributing Hardy\u2013Weinberg disequilibrium to population stratification and genetic association in case\u2013control studies","volume":"74","author":"Grover","year":"2010","journal-title":"Annals of Human Genetics"},{"key":"10.1016\/j.dld.2012.12.017_bib0090","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/S0002-9440(10)63911-9","article-title":"Exploration of global gene expression patterns in pancreatic adenocarcinoma using cDNA microarrays","volume":"162","author":"Iacobuzio-Donahue","year":"2003","journal-title":"American Journal of Pathology"},{"key":"10.1016\/j.dld.2012.12.017_bib0095","doi-asserted-by":"crossref","first-page":"10869","DOI":"10.1073\/pnas.191367098","article-title":"Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications","volume":"98","author":"Sorlie","year":"2001","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.dld.2012.12.017_bib0100","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/gene.2011.88","article-title":"Macrophage-stimulating protein polymorphism rs3197999 is associated with a gain of function: implications for inflammatory bowel disease","volume":"13","author":"H\u00e4user","year":"2012","journal-title":"Genes & Immunity"},{"key":"10.1016\/j.dld.2012.12.017_bib0105","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.2174\/138945010792006825","article-title":"The macrophage stimulating protein\/Ron pathway as a potential therapeutic target to impede multiple mechanisms involved in breast cancer progression","volume":"11","author":"Kretschmann","year":"2010","journal-title":"Current Drug Targets"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865812004951?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865812004951?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,9]],"date-time":"2019-07-09T16:59:37Z","timestamp":1562691577000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1590865812004951"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":21,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["S1590865812004951"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2012.12.017","relation":{},"ISSN":["1590-8658"],"issn-type":[{"value":"1590-8658","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]}}}